Icke-inlagda patienter” - nomesco

Table 23 Continued
THE HEALTH OF ELDERLY PEOPLE
Denmark Finland Åland Iceland Norway Sweden
Anxiolytics (N05B)
Men
0-64 10.9 22.7 3.4 10.8 13.5 10.3
65-69 25.1 28.9 3.5 46.0 29.3 22.2
70-74 26.2 29.3 12.0 46.1 30.1 22.8
75-79 27.3 30.0 5.2 41.5 26.7 25.1
80-84 26.8 33.1 15.0 35.4 31.9 28.8
85+ 24.3 30.6 15.0 24.1 30.4 37.1
Women
0-64 15.4 18.2 4.5 17.2 8.2 12.9
65-69 54.8 35.3 4.4 71.6 26.4 33.0
70-74 59.7 36.7 14.5 78.1 29.5 33.9
75-79 59.6 41.1 15.7 66.2 32.5 39.0
80-84 55.1 38.2 19.3 53.6 34.5 44.7
85+ 45.8 35.0 13.6 31.2 34.9 56.8
Hypnotics and sedatives
(N05C)
Men
0-64 12.7 18.8 6.2 20.4 16.6 22.2
65-69 49.6 70.2 28.5 124.0 62.9 73.5
70-74 62.6 91.1 52.0 150.6 80.2 90.7
75-79 76.0 123.3 78.4 177.5 90.9 118.9
80-84 96.0 167.4 93.2 198.9 135.8 158.1
85+ 115.3 212.8 210.4 168.2 172.8 239.3
Women
0-64 18.9 22.7 8.2 39.2 27.9 35.5
65-69 88.8 87.4 45.0 196.7 115.6 116.7
70-74 107.1 112.9 65.3 234.3 137.0 136.1
75-79 130.0 151.4 100.3 258.3 170.3 170.6
80-84 150.8 188.9 144.3 245.5 204.5 212.2
85+ 174.7 212.4 185.8 164.2 228.6 293.9
Antipsychotics (N05A)
Men
0-64 12.5 16.4 7.3 9.7 9.2 8.6
65-69 11.3 17.1 5.6 10.1 11.4 11.4
70-74 8.8 13.2 9.8 7.0 8.5 9.6
75-79 7.9 9.6 2.7 6.2 6.0 8.7
80-84 7.3 8.4 14.9 4.2 5.5 8.6
85+
Women
8.3 7.7 6.7 1.9 4.5 9.6
0-64 10.5 13.7 5.8 8.2 4.1 7.5
65-69 15.1 19.3 13.7 11.5 7.1 13.3
70-74 13.6 15.9 11.0 12.5 6.0 11.9
75-79 12.6 13.0 8.5 6.1 5.4 10.8
80-84 12.5 11.2 13.7 5.2 5.0 11.3
85+ 12.9 9.9 7.9 3.0 4.4 14.4
Sources D: Danish Medicines Agency; Fl: Chief Pharmaceutical Officer; G: Medical Officer; F & Å: National
Agency for Medicines; I: Icelandic Medicines Control Agency; N: WHO Collaborating Centre for
Drug Statistics Methodology; S: National Corporation of Swedish Pharmacies
333